Saint Herblain (France), July, 11 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that the European Medicines Agency (EMA) will lift the temporary restriction on vaccinating people aged 65 years and above after concluding a thorough review of Valneva’s single-dose chikungunya vaccine IXCHIQ® by EMA’s safety committee (PRAC). The committee initiated its review at the beginning of May following the occurrence of serious side effects mainly in elderly people ...

Saint Herblain (France), July, 11 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that the European Medicines Agency (EMA) will lift the temporary restriction on vaccinating people aged 65 years and above after concluding a thorough review of Valneva’s single-dose chikungunya vaccine IXCHIQ® by EMA’s safety committee (PRAC). The committee initiated its review at the beginning of May following the occurrence of serious side effects mainly in elderly people ...

I'm joined now by Congressman Na Nathaniel Moran. He's a Republican from Texas. He's a co-sponsor of the Rural Weather Monitoring Systems Act.Uh Congressman, uh again, just our thoughts and prayers are with everyone in your district and beyond who are dealing with this awful tragedy. But let's talk about the situation. Texas officials, particularly in Kirk County, have not really addressed questions about why the community was not more prepared for this flooding event.Do you feel that the community is owed ...

MINNEAPOLIS, July 10, 2025 (GLOBE NEWSWIRE) -- Northern Technologies International Corporation (NASDAQ: NTIC), a leading developer of corrosion inhibiting products and services, as well as bio-based and biodegradable polymer resin compounds, today reported its financial results for the third quarter of fiscal 2025. Third-quarter fiscal 2025 financial and operating highlights include (with growth rates on a fiscal quarter year-over-year basis): Consolidated net sales increased 4.0% to $21,509,000ZERUST® ind ...

Group 1: Land Resources in Jiangsu Province - Jiangsu Province covers an area of 107,200 square kilometers, accounting for 1.12% of the national land area, primarily consisting of fertile plains suitable for agricultural development [1] Group 2: Soil Pollution Monitoring and Status - In 2023, Jiangsu conducted soil quality monitoring at 778 national monitoring sites, with 94.7% of points showing pollutant levels below risk screening values, indicating overall good soil quality, although construction land pollution remains a concern [2][4] - The province has 87 contaminated sites pending control or remediation as of May 2025, with 57 sites successfully removed from the pollution risk management and remediation list since 2020 [8] Group 3: Fertilizer Usage Trends - Jiangsu has seen a continuous decline in fertilizer usage since 2010, with 2023 usage at 2.6704 million tons, projected to decrease to 2.6126 million tons in 2024 [7] Group 4: Soil Pollution Prevention Funding - The budget for soil pollution prevention in Jiangsu for 2025 is set at 13.839 million yuan, following a peak funding of nearly 200 million yuan in 2022 [11] Group 5: Environmental Safety Goals - The Jiangsu government aims for a 93% safety utilization rate of contaminated farmland by 2025, with a focus on both agricultural and construction land soil safety [12][15]

Ticks are flourishing in many parts of the U.S. Here's what you can do. https://t.co/PeU4qHbjGr ...

In 2012, the New York Times published an incredibly powerful story about how a father angrily walked into a Target store holding a handful of coupons for pregnancy related items like baby clothes and cribs in maternity wear. He demanded to speak with the manager and yelled at the manager. My daughter got these coupons in the mail.She's just in high school. Are you encouraging her to become pregnant at this age. The store manager was obviously confused, having no idea what the father was talking about, but h ...

Key Takeaways GILD stock has surged 27.2% in six months, outpacing its industry, sector, and the S&P 500 index. FDA approval of Yeztugo, the first twice-yearly PrEP, strengthens GILD's HIV portfolio and market edge. New liver drug Livdelzi and rising earnings estimates support GILD's growth and dividend sustainability.Shares of Gilead Sciences, Inc. (GILD) have gained 27.2% in the past six months against the industry’s decline of 2.2%. The stock has also outperformed the sector and the S&P 500 index in th ...

Instead of celebrating a landmark HIV prevention drug, aid groups are scrambling to keep those already infected alive after Trump's gutting of the global health infrastructure, @lisamjarvis says (via @opinion) https://t.co/SGDWStQrGQ ...

FORWARD-LOOKNG STATEMENTS & DISCLOSURES MAY 3, 2022 © 2022 Esperion. All Rights Reserved – For investor audience only WHEN DO YOU PLAN TO GET YOUR NEXT CHOLESTEROL TEST? This presentation contains forward-looking statements that are made pursuant to the safe harbor provisions of the federal securities laws, including statements regarding marketing strategy and commercialization plans, current and planned operational expenses, future operations, commercial products, clinical development, including the timing ...